Stay updated on Inhaled ZYESAMI Clinical Trial
Sign up to get notified when there's something new on the Inhaled ZYESAMI Clinical Trial page.

Latest updates to the Inhaled ZYESAMI Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page displays a 403 Forbidden error, replacing the normal study details and navigation with an error screen.SummaryDifference19%

- Check36 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6, indicating a small update to the page metadata.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing v3.6.4, representing a metadata version update rather than a change to study content.SummaryDifference0.0%

- Check72 days agoChange DetectedA new Revision: v3.6.4 appears, replacing Revision: v3.6.3, indicating an update to the page’s version rather than changes to the study content. This reflects a backend or template update rather than substantive changes to the study details.SummaryDifference0.0%

- Check86 days agoChange DetectedThe sponsor name APR Applied Pharma Research s.a. and the Pathogenesis of COVID-19 from a cell biologic perspective section have been removed. The Helpful Links Provided by section is also deleted, reducing background context and source attribution on the study details page.SummaryDifference0.1%

- Check93 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, indicating a minor update to the ClinicalTrials.gov record. This does not modify the study details, eligibility criteria, or results.SummaryDifference0.0%

Stay in the know with updates to Inhaled ZYESAMI Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled ZYESAMI Clinical Trial page.